Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lilly Teams Up With Boehringer Ingelheim To Boost Abemaciclib

Executive Summary

The two big pharmas are working together in oncology in an effort to advance combination therapies in both their growing, but young oncology pipelines.


Related Content

Boehringer Increasingly Looking Outside For Oncology Growth
Lilly's Abemaciclib Hit Leaves It Down But Not Out
Lilly Awaits New Rewards For SGLT-2 Diabetes Drug Jardiance
2Q Pharma Results Preview: What Lies Ahead
Deal Watch: Flagship Ventures Doubles Down On Microbiome
Lilly Playing Catch Up In Oncology
ASCO Puts A Spotlight On CDK4/6 Category Ahead Of New Competition


Related Companies